Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 13.40
-0.10 (-0.74%)
May 29, 2026, 12:26 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 586.54 million as of May 29, 2026. Its market cap has increased by 4.28% in one year.
Market Cap
586.54M
Enterprise Value
416.68M
Revenue
61.41M
Ranking
n/a
PE Ratio
6.12
Stock Price
13.40
Market Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 586.54M, an increase of 49.16%. That is a compound annual growth rate of 3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 586.54M | -4.29% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LabTurbo Biotech | 1.01B |
| U-Neuron Biomedical | 994.36M |
| TCI GENE | 976.32M |
| Taiwan Advance Bio-Pharmaceutical | 922.50M |
| NatureWise Biotech & Medicals | 895.40M |
| MegaPro Biomedical | 844.61M |
| Neith | 833.08M |
| BioLASCO Taiwan | 731.22M |